Generex Biotechnology receives Australian patent

Company Expands Drug Delivery Platform Patent Portfolio

08-Sep-2005

Generex Biotechnology Corporation announced that it has been granted a patent by the Australian Patent Office titled "Mixed Micellar Pharmaceutical Delivery System and Method of Preparation." The patent, an extant United States Patent registered by the Company, relates to an improved delivery system for the administration of large-molecule pharmaceuticals, particularly through the oral and nasal membranes.

The patent covers formulations for the delivery of peptidic drugs, vaccines, and hormones and enhances the Company's existing drug delivery patent portfolio. The Company currently holds an aggregate of 70 patents (17 of which are United States patents) and has an aggregate of 60 patent applications pending in various jurisdictions.

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances